George Soros’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,371,249
Closed -$202M 214
2025
Q1
$202M Sell
1,371,249
-206,652
-13% -$29.9M 3.01% 3
2024
Q4
$207M Buy
1,577,901
+251,515
+19% +$35.2M 3.11% 3
2024
Q3
$207M Buy
1,326,386
+100,617
+8% +$16.2M 2.99% 3
2024
Q2
$191M Buy
1,225,769
+1,025,769
+513% +$154M 3.44% 4
2024
Q1
$27.1M Buy
+200,000
New +$26.5M 0.45% 64
2014
Q4
Sell
-150,000
Closed -$10.7M 197
2014
Q3
$10.7M Hold
150,000
0.08% 160
2014
Q2
$11.1M Buy
+150,000
New +$10.8M 0.08% 161

Other funds holding AZN

George Soros's AZN Position: Q2 2025 in Review

George Soros sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 1,371,249 shares — an estimated $202M sold.

George Soros first reported a position in AZN in Q2 2014 and held it in 7 quarters. The position peaked at $207M in Q4 2024. 1,223 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

  • George Soros reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
  • George Soros sold 1,371,249 AstraZeneca shares in Q2 2025, an estimated $202M.
  • George Soros first reported a position in AstraZeneca in Q2 2014 and held it in 7 quarters.
  • George Soros's AstraZeneca position peaked at $207M in Q4 2024.
  • 1,223 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on Soros Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.